investorscraft@gmail.com

Intrinsic Value of Align Technology, Inc. (ALGN)

Previous Close$199.31
Intrinsic Value
Upside potential
Previous Close
$199.31

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Align Technology, Inc. is a global leader in the medical device industry, specializing in innovative orthodontic solutions. The company’s flagship product, Invisalign, is a clear aligner system that has revolutionized teeth straightening, offering a discreet and convenient alternative to traditional braces. Align also provides digital scanning solutions through its iTero intraoral scanners, which enhance treatment planning and patient engagement. The company operates in a highly competitive but growing sector, driven by increasing demand for aesthetic dental treatments and technological advancements in orthodontics. Align’s direct-to-consumer and professional channels, combined with strong brand recognition, position it as a dominant player in the clear aligner market. Its global footprint and continuous R&D investments further solidify its competitive edge, enabling it to cater to diverse patient needs across multiple demographics.

Revenue Profiability And Efficiency

Align Technology reported revenue of $3.99 billion for FY 2024, reflecting steady growth in its core markets. Net income stood at $421.4 million, with diluted EPS of $5.62, indicating robust profitability. Operating cash flow was $738.2 million, demonstrating strong cash generation capabilities. Capital expenditures totaled $115.6 million, highlighting disciplined investment in growth initiatives. The company’s ability to maintain high margins underscores its operational efficiency and pricing power in the orthodontic sector.

Earnings Power And Capital Efficiency

Align’s earnings power is supported by its premium product offerings and scalable business model. The company’s return on invested capital remains healthy, driven by high-margin clear aligner sales and recurring revenue from scanner services. With minimal debt and substantial cash reserves, Align is well-positioned to reinvest in innovation and expand its market share without compromising financial stability.

Balance Sheet And Financial Health

Align Technology maintains a strong balance sheet, with $1.04 billion in cash and equivalents and only $119.3 million in total debt. This low leverage ratio provides significant financial flexibility. The company’s liquidity position is robust, ensuring it can meet short-term obligations and fund strategic initiatives without undue reliance on external financing.

Growth Trends And Dividend Policy

Align has consistently delivered revenue growth, driven by increasing adoption of Invisalign and iTero scanners. The company does not currently pay dividends, opting instead to reinvest profits into R&D and global expansion. This strategy aligns with its focus on long-term growth and market penetration, particularly in emerging markets where demand for orthodontic solutions is rising.

Valuation And Market Expectations

The market values Align Technology at a premium, reflecting its leadership position and growth potential. Investors anticipate sustained revenue expansion, supported by technological innovation and increasing global demand for aesthetic dental treatments. Valuation multiples remain elevated, indicating high expectations for future earnings and market share gains.

Strategic Advantages And Outlook

Align’s strategic advantages include its strong brand, proprietary technology, and extensive clinical data supporting Invisalign’s efficacy. The company is well-positioned to capitalize on trends toward digital dentistry and personalized orthodontic care. Near-term challenges include competitive pressures and macroeconomic uncertainties, but long-term prospects remain favorable given its innovation pipeline and global growth opportunities.

Sources

10-K, Investor Presentations

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount